- Stronger Yuan Needed for Global Rebalancing: IMF Chief
- Gold Hits Record $1,130 as Dollar Drifts Lower
- Japan Third Quarter GDP Jumps; 2010 Growth May Slow
- Analysis: APEC Nations Back Face-Saving Climate Plan
- Shift Into High-Quality Stocks Could Move Market Higher
- Drug Study Questions Effectiveness of Merck's Drugs
- Cities With the Most Home Price Reductions
- Military Arms Race Dominates Dubai Air Show
- Buffett: I Haven't Bought AMEX Shares in Years
- Warren Buffett to CNBC: 'I Haven't Bought American Express In Years'
- CNBC Video: Warren Buffett & Bill Gates - Keeping American Great
- U.S. Stocks Rally for the Second Straight Week
- Dollar is Not Plunging—So 'Calm Down': Market Strategist
- Strategists Say Markets Have More Upside — But How Much?
- Hirschhorn: Risk-Averse Traders
- Roginsky: A Funny Thing Happened on the Way to Financial Reform
- This Year's Biggest Thanksgiving Leftover: Cash
- TV Series Inks Unique Deal For Fight
MOST SHARED
- U.S. May Wind Up Green With Envy
- Warren Buffett to CNBC: 'I Haven't Bought American Express In Years'
- Japan Third Quarter GDP Jumps; 2010 Growth May Slow
- CNBC Video: Warren Buffett & Bill Gates - Keeping American Great
- Analysis: APEC Nations Back Face-Saving Climate Plan
- Disaster Film '2012' Drowns Rivals at Box Office
- The Cost of Thanksgiving Dinner 2009
- For Investors, The New Green Looks To Be White
- Dipping Into Green Investing
- Stronger Yuan Needed for Global Rebalancing: IMF Chief
Text Size 
Pfizer, which is struggling to remain competitive amid generic competition for many of its products, Wednesday said it hopes to expand its sales in Asia and other emerging markets.
The world's largest drugmaker also said in a release, ahead of a meeting with industry analysts, that it will establish a new business unit focusing on cancer drugs and aims to significantly boost the number of its drugs in late-stage trials by late next year.
Pfizer [PFE
Loading...
()
] in the past year has cut more than 10,000 jobs and is paring other costs to keep earnings growing amid generic competition for antidepressant Zoloft, blood pressure treatment Norvasc and its Zyrtec antihistamine. It is also bracing for the U.S. patent expiration, possibly by 2010, for its Lipitor cholesterol fighter.
Pfizer shares were up nearly 1 percent in premarket trading.
Print
Email
- Where, what, how.
- Warren Buffett and Bill Gates spoke to Columbia students, and Buffett made the students a startling offer.
- For the chief of cable company Comcast, growth has been about making deals – generally very large deals.
- Some companies may start using insurance to shift carbon risk from their balance sheets to maybe... yours?
- The president and founder of Genesis Today wants to improve America’s health, and thinks Wal-Mart can help.
- Switzerland's privacy watchdog is taking legal action to force Google to make changes to its Street View service.
Data is a real-time snapshot *Data is delayed at least 15 minutes